MedicarePartD.guide

A non-government resource built from CMS public data

JAK inhibitors and other oral immunology drugs on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
JAK inhibitors and other oral immunology drugs by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
RinvoqupadacitinibTier 5PA25%QL 360/30dTier 5PA25%QL 360/30dTier 5PA25%QL 360/30dTier 5PA26%QL 360/30dTier 5PA25%QL 360/30dNot coveredTier 5PA25%QL 360/30dTier 5PA25%QL 360/30dTier 5PA31%QL 360/30dTier 5PA33%QL 360/30d
XeljanztofacitinibNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
OlumiantbaricitinibNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
OtezlaapremilastNot coveredTier 5PA25%QL 60/30dTier 5PA25%QL 60/30dNot coveredTier 5PA25%QL 60/30dTier 5PA25%QL 60/30dTier 5PA25%QL 60/30dNot coveredTier 5PA31%QL 60/30dNot covered
SotyktudeucravacitinibNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 30/30dTier 5PA31%QL 30/30dNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.